BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 37170098)

  • 1. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy.
    Hellevik T; Berzaghi R; Lode K; Islam A; Martinez-Zubiaurre I
    J Transl Med; 2021 Oct; 19(1):437. PubMed ID: 34663337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts.
    Ansems M; Span PN
    Clin Transl Radiat Oncol; 2020 May; 22():90-97. PubMed ID: 32337377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells.
    Yang N; Lode K; Berzaghi R; Islam A; Martinez-Zubiaurre I; Hellevik T
    Front Immunol; 2020; 11():602530. PubMed ID: 33584669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer.
    Sun H; Wang X; Wang X; Xu M; Sheng W
    Cell Death Dis; 2022 Oct; 13(10):874. PubMed ID: 36244987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts.
    Grinde MT; Vik J; Camilio KA; Martinez-Zubiaurre I; Hellevik T
    Sci Rep; 2017 Apr; 7():46714. PubMed ID: 28440285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts in neoadjuvant setting for solid cancers.
    Gu Y; Chen Q; Yin H; Zeng M; Gao S; Wang X
    Crit Rev Oncol Hematol; 2024 Jan; 193():104226. PubMed ID: 38056580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
    Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
    Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities.
    Wang Z; Tang Y; Tan Y; Wei Q; Yu W
    Cell Commun Signal; 2019 May; 17(1):47. PubMed ID: 31101063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
    Zhang Q; Wang Y; Liu F
    Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts: Secretions, interactions, and therapy.
    Farhood B; Najafi M; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2791-2800. PubMed ID: 30260049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic Nanoplatform for Dual-Targeted Clearance of Activated and Senescent Cancer-Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer.
    Jian C; Wu T; Wang L; Gao C; Fu Z; Zhang Q; Shi C
    Small; 2024 Jun; 20(25):e2309279. PubMed ID: 38214439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAF-immune cell crosstalk and its impact in immunotherapy.
    Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
    Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from cancer-associated fibroblasts mediate response to cancer therapy.
    Masoudi-Khoram N; Soheilifar MH; Ghorbanifar S; Nobari S; Hakimi M; Hassani M
    Crit Rev Oncol Hematol; 2023 May; 185():103967. PubMed ID: 36965647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.